Email This Article
Headlines & Perspectives
Chelsea Just Got Riskier: BioBuzz
By
Adam Feuerstein
11/03/09 - 10:41 AM EST
Change sought in a phase III trial adds risk and uncertainty.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,611.84 | 1,150.24 | 2,368.46 | 37.20 |
Oil *
80.39
|
|
UP
44.51
|
UP
4.63
|
UP
9.51
|
UP
0.00
|
10 Yr
3.72%
SPDR Gold
108.60
|
|
+0.42%
|
+0.40%
|
+0.40%
|
+0.00%
|
Data delayed 20 minutes |
More From TheStreet
Latest Headlines
Brokerage Partners
Sponsored Links
Connect with TheStreet